November 10, 2021
MSD said on November 9 that it released its antibiotic injection Recarbrio (relebactam + imipenem + cilastatin) in Japan on the same day. This is the country’s first drug combining a carbapenem antibiotic with a β-lactamase inhibitor. Recarbrio combines the...read more